Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow Up of VOY-101 for Advanced Non-Neovascular Age-Related Macular Degeneration Extension Study

NCT07660640 is registered in ClinicalTrials.gov with Perceive Biotherapeutics, Inc. as lead sponsor.

NCT NCT07660640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07660640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow Up of VOY-101 for Advanced Non-Neovascular Age-Related Macular Degeneration Extension Study
Lead sponsor
Perceive Biotherapeutics, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 3, 2026
Completion date
August 30, 2031
Enrollment
88 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration (amd), non-neovascular age-related macular degeneration